Loading insider details...
Beta
Latest Form 4 (Jul 31, 2026): Exercise/Conversion of 32,272 ACAD shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 31, 2026 | ACADIA PHARMACEUTICALS INC (ACAD) | Exercise/Conversion | 32,272 | n/a |
| Mar 27, 2026 | ACADIA PHARMACEUTICALS INC (ACAD) | Exercise/Conversion | 6,715 | n/a |
| Mar 10, 2026 | ACADIA PHARMACEUTICALS INC (ACAD) | Grant/Award | 101,574 | n/a |
| Mar 26, 2025 | ACADIA PHARMACEUTICALS INC (ACAD) | Grant/Award | 91,395 | n/a |
| Oct 2, 2024 | IGM Biosciences, Inc. (IGMS) | Grant/Award | 1,452 | n/a |
| Aug 13, 2024 | ACADIA PHARMACEUTICALS INC (ACAD) | Grant/Award | 324,582 | n/a |
| Jul 2, 2024 | IGM Biosciences, Inc. (IGMS) | Grant/Award | 1,452 | n/a |
| Apr 2, 2024 | IGM Biosciences, Inc. (IGMS) | Grant/Award | 1,452 | n/a |
| Mar 14, 2024 | IGM Biosciences, Inc. (IGMS) | Grant/Award | 29,400 | n/a |